Get affordable, high-quality Leukemia Chronic Myeloid Cml at India's best hospitals. With 3 advanced treatment options, success rates matching Western standards, and savings of 60-80%, India is the top choice for international patients seeking expert General Medicine care.
People with CML have an acquired genetic abnormality or mutation in their bone marrow cells, in which one chromosome (a long strand of genes) breaks off and reattaches to another chromosome. This type of genetic exchange is called a translocation. In CML, part of chromosome 9 breaks off and fuses to a section of chromosome 22, and it is called the Philadelphia chromosome or Ph chromosome. The translocation causes two genes called BCR and ABL to fuse into one gene called BCR-ABL. This mutation is found only in the blood-forming cells, not in other organs of the body, and is not inherited. Hence, there is no concern about an increased risk to other family members.
A risk factor is anything that increases a person's chance of developing cancer. Some risk factors can be controlled, such as smoking, and some cannot be controlled, such as age and family history. Although risk factors can influence the development of cancer, most do not directly cause cancer. Some people with several risk factors never develop cancer, while others with no known risk factors do. However, knowing your risk factors and communicating them to your doctor may help you make more informed lifestyle and health-care choices.
The cause of CML is not known, though researchers now understand how the disease develops from genetic changes in myeloid cells. Environmental factors account for only a small number of CML cases, and family history does not appear to play a role in the development of CML.
The following factors may raise a person's risk of developing CML:
Age. Risk of CML is higher in adults older than 60, as this cancer is most prevalent later in life. CML is uncommon in children and adolescents.
Radiation exposure. There was an increase in the rate of CML seen in Japan in long-term survivors of the atomic bombings. However, there is no proven link in the occurrence of CML following radiation therapy or chemotherapy given for other types of cancer or other diseases.
Gender. Men have a slightly higher risk of CML than women.
Recognising these signs early can help you seek timely treatment and achieve the best possible outcomes.
A new lump, growth or swelling that is painless, firm, and growing — the most common early sign of cancer that requires immediate biopsy.
Losing more than 5 kg without trying — a systemic sign of cancer that affects the body's metabolism and nutritional status.
Extreme tiredness unrelated to activity or sleep — caused by cancer cells consuming the body's energy resources and bone marrow infiltration.
Yellowing of skin/eyes (jaundice), blood in urine or stool, change in bowel habits persisting more than 4 weeks — potential signs of GI or GU malignancy.
Drenching night sweats, persistent low-grade fever, and recurring infections — classic 'B symptoms' of lymphoma and haematological cancers.
Raised tumour markers (PSA, CEA, CA-125, AFP), abnormal lymph nodes on CT/PET-CT, or suspicious finding on MRI requiring oncology evaluation.
India ranks among the top 5 global destinations for medical tourism
40+ JCI-accredited hospitals across major cities
Over 500,000 international patients treated annually
Average savings of 70-80% on treatment costs
India has become a preferred destination for international patients seeking Leukemia, Chronic Myeloid (CML) treatment. With over 500,000 medical tourists annually, India's healthcare infrastructure is well-equipped to handle complex cases with outcomes comparable to Western countries.
The key advantage of seeking Leukemia, Chronic Myeloid (CML) treatment in India is the combination of world-class medical expertise and significant cost savings. Patients save 60-85% while receiving care at hospitals that meet the same accreditation standards as top US and UK institutions.
Our partner hospitals offer multiple evidence-based treatment approaches. Your specialist will recommend the most appropriate option.
Thorough diagnostic workup using advanced imaging and laboratory investigations to accurately assess Leukemia, Chronic Myeloid (CML) and plan optimal treatment.
Evidence-based non-surgical approaches that may be appropriate as first-line treatment depending on the severity of Leukemia, Chronic Myeloid (CML).
State-of-the-art surgical treatment for Leukemia, Chronic Myeloid (CML) performed by fellowship-trained specialists using the latest technology and minimally invasive techniques where possible.
Comprehensive recovery programme including physiotherapy, pain management, and long-term follow-up to ensure optimal outcomes.
India offers world-class care at a fraction of the cost. All costs below are approximate and vary by hospital and case complexity.
| Procedure | India (USD) | USA / UK | Savings |
|---|---|---|---|
| Leukemia Chronic Myeloid Cml (Standard) | $5,000-12,000 | $30,000-60,000 | Save 70-80% |
| Leukemia Chronic Myeloid Cml (Complex) | $10,000-20,000 | $50,000-100,000 | Save 75-85% |
| Pre-op Tests & Evaluation | $200-500 | $2,000-5,000 | Save 80-90% |
India's top hospitals meet the same quality standards as US and European hospitals.
Fellowship-trained specialists with decades of experience and international training.
Same quality treatment at a fraction of Western prices, saving tens of thousands of dollars.
Treatment begins within days, not months. Priority scheduling for international patients.
Visa assistance, airport transfers, accommodation, and dedicated patient coordinator.
All consultations and reports in English. Arabic, French, and Russian interpreters available.
"The treatment I received in India was outstanding. The doctors were highly experienced and the hospital facilities were world-class. I saved over 70% compared to my home country."
"Indian Med Guru coordinated everything perfectly - from visa to hospital to recovery. The quality of care was exceptional and the cost was a fraction of what I was quoted in the UK."
"My family member received excellent treatment. The coordinator guided us through every step. We are grateful for the care and attention we received throughout our stay in India."
Share your medical reports with our team. A specialist will review your case and provide a personalised treatment recommendation - completely free, within 24 hours.
Everything you need to know about Leukemia Chronic Myeloid Cml treatment in India.
Send your medical reports now and receive a free personalised treatment plan from India's leading specialists within 24 hours.
Disclaimer: The information provided on this page is intended for general educational purposes only and does not constitute medical advice, diagnosis, or treatment.